Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Oncolytics Biotech Inc. (ONCY)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9100-0.0600 (-3.05%)
At close: 04:00PM EST
1.9900 +0.08 (+4.19%)
After hours: 07:46PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Head and Shoulders Bottom

Head and Shoulders Bottom

Previous Close1.9700
Open1.9900
Bid1.8300 x 3200
Ask1.9800 x 1200
Day's Range1.8201 - 2.0200
52 Week Range1.2500 - 4.8300
Volume1,015,072
Avg. Volume363,282
Market Cap105.319M
Beta (5Y Monthly)1.79
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ONCY

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Oncolytics Biotech Inc.
    LGND: Lowering target price to $130.00LIGAND PHARMACEUTICALS has an Investment Rating of BUY; a target price of $130.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
Advertisement
Advertisement